Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
9553 | 1145 | 51.4 | 90% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
12 | 4 | POLYMER SCIENCE//MATERIALS SCIENCE, PAPER & WOOD//CHEMISTRY, PHYSICAL | 1084170 |
41 | 3 | INTERNATIONAL JOURNAL OF PHARMACEUTICS//DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY//PHARMACOLOGY & PHARMACY | 99449 |
147 | 2 | SOLID LIPID NANOPARTICLES//POLYMERIC MICELLES//LIPOSOMES | 23275 |
9553 | 1 | CANCER NANOTECHNOLOGY//SHENZHEN GENE ANTIBODY THER Y//NANOSCI NANOENGN INITIAT NUSNNI | 1145 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CANCER NANOTECHNOLOGY | authKW | 914790 | 5% | 64% | 54 |
2 | SHENZHEN GENE ANTIBODY THER Y | address | 460061 | 3% | 49% | 35 |
3 | NANOSCI NANOENGN INITIAT NUSNNI | address | 418547 | 2% | 83% | 19 |
4 | CHEMOTHERAPEUTIC ENGINEERING | authKW | 400003 | 1% | 100% | 15 |
5 | TPGS | authKW | 252592 | 3% | 32% | 30 |
6 | CO DELIVERY | authKW | 197408 | 4% | 18% | 41 |
7 | MOLECULAR BIOMATERIALS | authKW | 196362 | 1% | 82% | 9 |
8 | PLGA NANOPARTICLES | authKW | 191266 | 3% | 18% | 40 |
9 | LIPID POLYMER HYBRID NANOPARTICLES | authKW | 190472 | 1% | 71% | 10 |
10 | PHARMACEUTICAL NANOTECHNOLOGY | authKW | 160940 | 1% | 46% | 13 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Materials Science, Biomaterials | 14223 | 19% | 0% | 212 |
2 | Pharmacology & Pharmacy | 5929 | 42% | 0% | 486 |
3 | Nanoscience & Nanotechnology | 3698 | 20% | 0% | 226 |
4 | Engineering, Biomedical | 2282 | 12% | 0% | 133 |
5 | Chemistry, Multidisciplinary | 684 | 18% | 0% | 208 |
6 | Medicine, Research & Experimental | 429 | 8% | 0% | 95 |
7 | Chemistry, Medicinal | 109 | 4% | 0% | 42 |
8 | Biotechnology & Applied Microbiology | 102 | 6% | 0% | 63 |
9 | Materials Science, Multidisciplinary | 92 | 10% | 0% | 113 |
10 | Polymer Science | 89 | 5% | 0% | 52 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SHENZHEN GENE ANTIBODY THER Y | 460061 | 3% | 49% | 35 |
2 | NANOSCI NANOENGN INITIAT NUSNNI | 418547 | 2% | 83% | 19 |
3 | NANOSCI NANOENGN INITIAT | 111110 | 0% | 83% | 5 |
4 | BIOTECH BIOMED | 77131 | 1% | 32% | 9 |
5 | ENGN NANOMED | 53726 | 1% | 13% | 16 |
6 | ANESTHESIA NANOMED BIOMAT | 53334 | 0% | 100% | 2 |
7 | EDWARD M COPELAND III CHAIR BREAST CANC | 53334 | 0% | 100% | 2 |
8 | EXPT PL PHARMACOKINET PHARMACODYNAM LEA | 53334 | 0% | 100% | 2 |
9 | HUBEI ENGN NDDS | 53334 | 0% | 100% | 2 |
10 | JSS PHARM OFF CAMPUS | 53334 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INTERNATIONAL JOURNAL OF NANOMEDICINE | 22452 | 5% | 2% | 52 |
2 | MOLECULAR PHARMACEUTICS | 14893 | 4% | 1% | 42 |
3 | BIOMATERIALS | 13430 | 8% | 1% | 87 |
4 | DRUG DELIVERY | 12811 | 2% | 2% | 25 |
5 | NANOMEDICINE | 12574 | 2% | 2% | 24 |
6 | NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE | 9139 | 2% | 2% | 21 |
7 | JOURNAL OF CONTROLLED RELEASE | 6579 | 4% | 1% | 43 |
8 | INTERNATIONAL JOURNAL OF PHARMACEUTICS | 6401 | 5% | 0% | 62 |
9 | JOURNAL OF BIOMEDICAL NANOTECHNOLOGY | 5798 | 2% | 1% | 18 |
10 | JOURNAL OF DRUG TARGETING | 4364 | 1% | 1% | 16 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CANCER NANOTECHNOLOGY | 914790 | 5% | 64% | 54 | Search CANCER+NANOTECHNOLOGY | Search CANCER+NANOTECHNOLOGY |
2 | CHEMOTHERAPEUTIC ENGINEERING | 400003 | 1% | 100% | 15 | Search CHEMOTHERAPEUTIC+ENGINEERING | Search CHEMOTHERAPEUTIC+ENGINEERING |
3 | TPGS | 252592 | 3% | 32% | 30 | Search TPGS | Search TPGS |
4 | CO DELIVERY | 197408 | 4% | 18% | 41 | Search CO+DELIVERY | Search CO+DELIVERY |
5 | MOLECULAR BIOMATERIALS | 196362 | 1% | 82% | 9 | Search MOLECULAR+BIOMATERIALS | Search MOLECULAR+BIOMATERIALS |
6 | PLGA NANOPARTICLES | 191266 | 3% | 18% | 40 | Search PLGA+NANOPARTICLES | Search PLGA+NANOPARTICLES |
7 | LIPID POLYMER HYBRID NANOPARTICLES | 190472 | 1% | 71% | 10 | Search LIPID+POLYMER+HYBRID+NANOPARTICLES | Search LIPID+POLYMER+HYBRID+NANOPARTICLES |
8 | PHARMACEUTICAL NANOTECHNOLOGY | 160940 | 1% | 46% | 13 | Search PHARMACEUTICAL+NANOTECHNOLOGY | Search PHARMACEUTICAL+NANOTECHNOLOGY |
9 | VITAMIN E TPGS | 155243 | 2% | 31% | 19 | Search VITAMIN+E+TPGS | Search VITAMIN+E+TPGS |
10 | TPGS B PCL RAN PGA | 85332 | 0% | 80% | 4 | Search TPGS+B+PCL+RAN+PGA | Search TPGS+B+PCL+RAN+PGA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | FENG, SS , ZHANG, ZP , TAN, SW , (2012) VITAMIN E TPGS AS A MOLECULAR BIOMATERIAL FOR DRUG DELIVERY.BIOMATERIALS. VOL. 33. ISSUE 19. P. 4889 -4906 | 59 | 53% | 133 |
2 | BERNABEU, E , CHIAPPETTA, DA , (2013) VITAMIN E TPGS USED AS EMULSIFIER IN THE PREPARATION OF NANOPARTICULATE SYSTEMS.JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING. VOL. 3. ISSUE 1. P. 122-134 | 49 | 47% | 6 |
3 | DINARVAND, R , SEPEHRI, N , MANOOCHEHRI, S , ROUHANI, H , ATYABI, F , (2011) POLYLACTIDE-CO-GLYCOLIDE NANOPARTICLES FOR CONTROLLED DELIVERY OF ANTICANCER AGENTS.INTERNATIONAL JOURNAL OF NANOMEDICINE. VOL. 6. ISSUE . P. 877 -895 | 47 | 32% | 110 |
4 | ZHENG, DH , ZHANG, RB , ZHANG, C , CHEN, K , WU, BQ , LIANG, Y , TAN, Y , XIE, CM , SHEN, J , ZHANG, M , ET AL (2016) GENISTEIN-LOADED NANOPARTICLES OF STAR-SHAPED DIBLOCK COPOLYMER MANNITOL-CORE PLGA-TPGS FOR THE TREATMENT OF LIVER CANCER.MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS. VOL. 59. ISSUE . P. 792 -800 | 24 | 62% | 3 |
5 | LIU, BY , WU, C , HE, XY , ZHUO, RX , CHENG, SX , (2016) MULTI-DRUG LOADED VITAMIN E-TPGS NANOPARTICLES FOR SYNERGISTIC DRUG DELIVERY TO OVERCOME DRUG RESISTANCE IN TUMOR TREATMENT.SCIENCE BULLETIN. VOL. 61. ISSUE 7. P. 552 -560 | 22 | 61% | 2 |
6 | VIJAYAKUMAR, MR , MUTHU, MS , SINGH, S , (2013) COPOLYMERS OF POLY(LACTIC ACID) AND D-ALPHA-TOCOPHERYL POLYETHYLENE GLYCOL 1000 SUCCINATE-BASED NANOMEDICINES: VERSATILE MULTIFUNCTIONAL PLATFORMS FOR CANCER DIAGNOSIS AND THERAPY.EXPERT OPINION ON DRUG DELIVERY. VOL. 10. ISSUE 4. P. 529-543 | 32 | 47% | 11 |
7 | DUHEM, N , DANHIER, F , PREAT, V , (2014) VITAMIN E-BASED NANOMEDICINES FOR ANTI-CANCER DRUG DELIVERY.JOURNAL OF CONTROLLED RELEASE. VOL. 182. ISSUE . P. 33-44 | 30 | 38% | 38 |
8 | ZHU, DW , TAO, W , ZHANG, HL , LIU, G , WANG, T , ZHANG, LH , ZENG, XW , MEI, L , (2016) DOCETAXEL (DTX)-LOADED POLYDOPAMINE-MODIFIED TPGS-PLA NANOPARTICLES AS A TARGETED DRUG DELIVERY SYSTEM FORE THE TREATMENT OF LIVER CANCER.ACTA BIOMATERIALIA. VOL. 30. ISSUE . P. 144 -154 | 20 | 39% | 13 |
9 | SONALI , AGRAWAL, P , SINGH, RP , RAJESH, CV , SINGH, S , VIJAYAKUMAR, MR , PANDEY, BL , MUTHU, MS , (2016) TRANSFERRIN RECEPTOR-TARGETED VITAMIN E TPGS MICELLES FOR BRAIN CANCER THERAPY: PREPARATION, CHARACTERIZATION AND BRAIN DISTRIBUTION IN RATS.DRUG DELIVERY. VOL. 23. ISSUE 5. P. 1788 -1798 | 22 | 58% | 1 |
10 | KHAN, I , GOTHWAL, A , SHARMA, AK , KESHARWANI, P , GUPTA, L , IYER, AK , GUPTA, U , (2016) PLGA NANOPARTICLES AND THEIR VERSATILE ROLE IN ANTICANCER DRUG DELIVERY.CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS. VOL. 33. ISSUE 2. P. 159 -193 | 40 | 34% | 0 |
Classes with closest relation at Level 1 |